Longitudinal In Vivo Assessment of Host-Microbe Interactions in a Murine Model of Pulmonary Aspergillosis
暂无分享,去创建一个
U. Himmelreich | A. Liston | C. Gysemans | B. Manshian | S. Soenen | S. D. De Smedt | I. Lentacker | Sayuan Liang | K. Lagrou | S. Saini | J. Poelmans | H. Korf | J. Dooley | Rein Verbeke | G. Vande Velde | Bella B. Manshian
[1] P. van Dijck,et al. Let’s shine a light on fungal infections: A noninvasive imaging toolbox , 2020, PLoS pathogens.
[2] D. He,et al. Aspergillus fumigatus enhances human NK cell activity by regulating M1 macrophage polarization , 2019, Molecular medicine reports.
[3] D. Irimia,et al. Bifunctional Small Molecules Enhance Neutrophil Activities Against Aspergillus fumigatus in vivo and in vitro , 2019, Front. Immunol..
[4] U. Himmelreich,et al. Challenges for labeling and longitudinal tracking of adoptively transferred autoreactive T lymphocytes in an experimental type-1 diabetes model , 2019, Magnetic Resonance Materials in Physics, Biology and Medicine.
[5] U. Dirnagl,et al. Longitudinal 19F magnetic resonance imaging of brain oxygenation in a mouse model of vascular cognitive impairment using a cryogenic radiofrequency coil , 2018, Magnetic Resonance Materials in Physics, Biology and Medicine.
[6] U. Himmelreich,et al. A Multimodal Imaging Approach Enables In Vivo Assessment of Antifungal Treatment in a Mouse Model of Invasive Pulmonary Aspergillosis , 2018, Antimicrobial Agents and Chemotherapy.
[7] U. Himmelreich,et al. Tri-modal In vivo Imaging of Pancreatic Islets Transplanted Subcutaneously in Mice , 2018, Molecular Imaging and Biology.
[8] U. Himmelreich,et al. Bronchoscopic fibered confocal fluorescence microscopy for longitudinal in vivo assessment of pulmonary fungal infections in free-breathing mice , 2018, Scientific Reports.
[9] S. Viswanathan,et al. 19F-perfluorocarbon-labeled human peripheral blood mononuclear cells can be detected in vivo using clinical MRI parameters in a therapeutic cell setting , 2018, Scientific Reports.
[10] Ling Lu,et al. Innate and adaptive immune response to chronic pulmonary infection of hyphae of Aspergillus fumigatus in a new murine model , 2017, Journal of medical microbiology.
[11] Ce Zhu,et al. Comparison of different compressed sensing algorithms for low SNR 19F MRI applications—Imaging of transplanted pancreatic islets and cells labeled with perfluorocarbons , 2017, NMR in biomedicine.
[12] C. Steele,et al. Innate Lung Defense during Invasive Aspergillosis: New Mechanisms , 2017, Journal of Innate Immunity.
[13] S. Leibundgut-Landmann,et al. Host response to fungal infections - how immunology and host genetics could help to identify and treat patients at risk. , 2016, Swiss medical weekly.
[14] H. Einsele,et al. Dynamic Immune Cell Recruitment After Murine Pulmonary Aspergillus fumigatus Infection under Different Immunosuppressive Regimens , 2016, Front. Microbiol..
[15] T. Dresselaers,et al. Longitudinal, in vivo assessment of invasive pulmonary aspergillosis in mice by computed tomography and magnetic resonance imaging , 2016, Laboratory Investigation.
[16] E. Fischer,et al. ImmunoPET/MR imaging allows specific detection of Aspergillus fumigatus lung infection in vivo , 2016, Proceedings of the National Academy of Sciences.
[17] Eric T. Ahrens,et al. In Vivo Quantification of Inflammation in Experimental Autoimmune Encephalomyelitis Rats Using Fluorine-19 Magnetic Resonance Imaging Reveals Immune Cell Recruitment outside the Nervous System , 2015, PloS one.
[18] K. Kavanagh,et al. The innate immune response to Aspergillus fumigatus at the alveolar surface. , 2015, FEMS microbiology reviews.
[19] M. Stuber,et al. Fluorine MR Imaging of Inflammation in Atherosclerotic Plaque in Vivo. , 2015, Radiology.
[20] Arend Heerschap,et al. Cell tracking using 19F magnetic resonance imaging: Technical aspects and challenges towards clinical applications , 2015, European Radiology.
[21] Uwe Himmelreich,et al. High-content imaging and gene expression analysis to study cell-nanomaterial interactions: the effect of surface hydrophobicity. , 2014, Biomaterials.
[22] E. Ahrens,et al. Clinical cell therapy imaging using a perfluorocarbon tracer and fluorine-19 MRI , 2014, Magnetic resonance in medicine.
[23] U. Himmelreich,et al. Magnetic layer-by-layer coated particles for efficient MRI of dendritic cells and mesenchymal stem cells. , 2014, Nanomedicine.
[24] Rolf Schubert,et al. Probing different perfluorocarbons for in vivo inflammation imaging by 19F MRI: image reconstruction, biological half‐lives and sensitivity , 2014, NMR in biomedicine.
[25] P. Heusch,et al. Visualization of immune cell infiltration in experimental viral myocarditis by 19F MRI in vivo , 2014, Magnetic Resonance Materials in Physics, Biology and Medicine.
[26] H. Sales-Campos,et al. The Immune Interplay between the Host and the Pathogen in Aspergillus fumigatus Lung Infection , 2013, BioMed research international.
[27] Sayuan Liang,et al. Design and evaluation of theranostic perfluorocarbon particles for simultaneous antigen-loading and ¹⁹F-MRI tracking of dendritic cells. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[28] Peter Jakob,et al. 19F Magnetic Resonance Imaging of Perfluorocarbons for the Evaluation of Response to Antibiotic Therapy in a Staphylococcus aureus Infection Model , 2013, PloS one.
[29] Mathias Hoehn,et al. Labeling cells for in vivo tracking using (19)F MRI. , 2012, Biomaterials.
[30] N. Yadav,et al. Applications of Steroid in Clinical Practice: A Review , 2012 .
[31] P. Jakob,et al. Visualization of inflammation using (19) F-magnetic resonance imaging and perfluorocarbons. , 2012, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[32] M. Hoehn,et al. Polyelectrolyte coating of iron oxide nanoparticles for MRI-based cell tracking. , 2012, Nanomedicine : nanotechnology, biology, and medicine.
[33] Sebastian Temme,et al. 19F magnetic resonance imaging of endogenous macrophages in inflammation. , 2012, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[34] E. Grabczak,et al. Tracheobronchial Manifestations of Aspergillus Infections , 2011, TheScientificWorldJournal.
[35] F. Paul,et al. Perfluorocarbon Particle Size Influences Magnetic Resonance Signal and Immunological Properties of Dendritic Cells , 2011, PloS one.
[36] A. Guerguerian,et al. Invasive aspergillosis in cystic fibrosis: a fatal case in an adolescent and review of the literature. , 2011, The Pediatric infectious disease journal.
[37] J. Bulte,et al. Fluorine (19F) MRS and MRI in biomedicine , 2011, NMR in biomedicine.
[38] F. Ebel,et al. Aspergillus fumigatus: contours of an opportunistic human pathogen , 2010, Cellular microbiology.
[39] Arend Heerschap,et al. Customizable, multi-functional fluorocarbon nanoparticles for quantitative in vivo imaging using 19F MRI and optical imaging. , 2010, Biomaterials.
[40] Arend Heerschap,et al. (19)F MRI for quantitative in vivo cell tracking. , 2010, Trends in biotechnology.
[41] B. A. French,et al. Early Assessment of Pulmonary Inflammation by 19F MRI In Vivo , 2010, Circulation. Cardiovascular imaging.
[42] Ashkan Emadi,et al. Cyclophosphamide and cancer: golden anniversary , 2009, Nature Reviews Clinical Oncology.
[43] E. Ahrens,et al. Fluorine-containing nanoemulsions for MRI cell tracking. , 2009, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[44] N. Keller,et al. Pathogenesis of Aspergillus fumigatus in Invasive Aspergillosis , 2009, Clinical Microbiology Reviews.
[45] M. Nicola,et al. Bioluminescent Aspergillus fumigatus, a New Tool for Drug Efficiency Testing and In Vivo Monitoring of Invasive Aspergillosis , 2008, Applied and Environmental Microbiology.
[46] Rolf Schubert,et al. In Vivo Monitoring of Inflammation After Cardiac and Cerebral Ischemia by Fluorine Magnetic Resonance Imaging , 2008, Circulation.
[47] Qing Ye,et al. In situ labeling of immune cells with iron oxide particles: an approach to detect organ rejection by cellular MRI. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[48] D. Kleiner,et al. Host-dependent patterns of tissue injury in invasive pulmonary aspergillosis. , 2005, American journal of clinical pathology.
[49] J. Latgé,et al. Differences in Patterns of Infection and Inflammation for Corticosteroid Treatment and Chemotherapy in Experimental Invasive Pulmonary Aspergillosis , 2005, Infection and Immunity.
[50] Shane D Stephens-Romero,et al. The Pathogenesis of Fatal Outcome in Murine Pulmonary Aspergillosis Depends on the Neutrophil Depletion Strategy , 2005, Infection and Immunity.
[51] T. Hitchens,et al. A non-invasive approach to detecting organ rejection by MRI: monitoring the accumulation of immune cells at the transplanted organ. , 2004, Current pharmaceutical biotechnology.
[52] T. Walsh,et al. Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin. , 2003, The Journal of infectious diseases.
[53] A. Hebert,et al. Neonatal Primary Cutaneous Aspergillosis: Case Report and Review of the Literature , 2002, Pediatric dermatology.
[54] M. Kamberi,et al. Regulation of bronchoalveolar macrophage proinflammatory cytokine production by dexamethasone and granulocyte-macrophage colony-stimulating factor after stimulation by Aspergillus conidia or lipopolysaccharide. , 2002, Cytokine.
[55] G. Sukhikh,et al. Mesenchymal Stem Cells , 2002, Bulletin of Experimental Biology and Medicine.
[56] A. Francesconi,et al. Antifungal Efficacy of Caspofungin (MK-0991) in Experimental Pulmonary Aspergillosis in Persistently Neutropenic Rabbits: Pharmacokinetics, Drug Disposition, and Relationship to Galactomannan Antigenemia , 2002, Antimicrobial Agents and Chemotherapy.
[57] E. Brummer,et al. In vivo GM‐CSF prevents dexamethasone suppression of killing of Aspergillus fumigatus conidia by bronchoalveolar macrophages , 2001, Journal of leukocyte biology.
[58] S J Lin,et al. Aspergillosis case-fatality rate: systematic review of the literature. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[59] T. Walsh,et al. Pulmonary host defences against Aspergillus fumigatus. , 1998, Research in immunology.
[60] A. Niimi,et al. Murine model of invasive pulmonary aspergillosis following an earlier stage, noninvasive Aspergillus infection , 1996, Journal of clinical microbiology.
[61] T. Walsh,et al. Pathogenesis of pulmonary aspergillosis. Granulocytopenia versus cyclosporine and methylprednisolone-induced immunosuppression. , 1995, American journal of respiratory and critical care medicine.
[62] Xinrong Liu,et al. Detection of Aspergillus fumigatus pulmonary fungal infections in mice with (99m)Tc-labeled MORF oligomers targeting ribosomal RNA. , 2013, Nuclear medicine and biology.